The cyclin dependent kinase inhibitor p21Cip1/Waf1 is a therapeutic target in high-risk neuroblastoma

细胞周期蛋白依赖性激酶抑制剂 p21Cip1/Waf1 是高危神经母细胞瘤的治疗靶点